To further confirm the high expression of RCN1 in AML, we assessed RCN1 mRNA levels by quantitative polymerase chain reaction (qPCR) in 43 BMMNC samples from AML patients and 45 G‐CSF‐mobilized PBSC samples from healthy donors. The gene discussed is RCN1; the disease is acute myeloid leukemia.